Loading compound...

Antibacterial agent (in development)

Solithromycin is a small molecule drug currently in clinical development (Phase 3). It is being studied for its ability to treat various bacterial infections, including gonorrhea, bacterial pneumonia, and other bacterial diseases. Research is also looking into its potential use for chronic obstructive pulmonary disease (COPD) and non-alcoholic steatohepatitis.

Used for
GonorrheaBacterial infectionsBacterial pneumoniaChronic obstructive pulmonary disease (COPD)Non-alcoholic steatohepatitis
Conditions
GonorrheaBacterial infectionsBacterial pneumoniaChronic obstructive pulmonary diseaseNon-alcoholic steatohepatitis
Class
Small moleculeAntibacterial agent (in development)RespiratoryGenitourinaryHepatic

How to take

Solithromycin is currently being studied in clinical trials and is not yet an approved medication for general use.

Talk to your doctor

Questions to ask

  • ·What stage of clinical trials is Solithromycin in?
  • ·How does Solithromycin differ from other antibiotics?
  • ·What are the potential side effects being studied for Solithromycin?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.